Current HIV/AIDS Reports

Papers
(The TQCC of Current HIV/AIDS Reports is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation95
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions80
The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future56
COVID-19 Outcomes and Risk Factors Among People Living with HIV40
ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities36
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies34
A Review of Interventions to Enhance HIV Medication Adherence31
Understanding Engagement in HIV Programmes: How Health Services Can Adapt to Ensure No One Is Left Behind31
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine28
Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV27
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa27
Social Network Interventions for HIV Transmission Elimination26
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations26
A Review of Usability Evaluation Methods and Their Use for Testing eHealth HIV Interventions25
Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer23
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs23
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management23
NASH in HIV23
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection22
A Cascade of Interventions to Promote Adherence to Antiretroviral Therapy in African Countries21
Latency Reversal 2.0: Giving the Immune System a Seat at the Table20
Exploring Relative Preferences for HIV Service Features Using Discrete Choice Experiments: a Synthetic Review20
Gastrointestinal Dysfunction and HIV Comorbidities19
A Systematic Review of Technology-Assisted HIV Testing Interventions19
Frailty in People Living with HIV19
Probing the Interface of HIV and Inflammaging18
Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention18
Social Determinants of Disease: HIV and COVID-19 Experiences17
Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men17
A Systematic Review of Recent Methodological Approaches for Using Ecological Momentary Assessment to Examine Outcomes in U.S. Based HIV Research17
Peer Group Focused eHealth Strategies to Promote HIV Prevention, Testing, and Care Engagement17
The Evidence for HIV Self-Testing to Increase HIV Testing Rates and the Implementation Challenges that Remain17
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa16
Machine Learning and Clinical Informatics for Improving HIV Care Continuum Outcomes16
Implementing a Status-Neutral Approach to HIV in the Asia-Pacific16
Frailty and HIV: Moving from Characterization to Intervention16
Community-Led Monitoring: When Community Data Drives Implementation Strategies15
Social and Behavioral Impacts of COVID-19 on People Living with HIV: Review of the First Year of Research15
Patient-Led Decision-Making for HIV Preexposure Prophylaxis15
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV13
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)13
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course13
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men13
Ethical Considerations in HIV eHealth Intervention Research: Implications for Informational Risk in Recruitment, Data Maintenance, and Consent Procedures13
Mpox and HIV: a Narrative Review12
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV12
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?12
Telehealth Interventions for HIV in Low- and Middle-Income Countries12
People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management11
HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis11
Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application11
Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research11
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review11
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review11
Neuroimaging the Neuropathogenesis of HIV11
Technology-Delivered Intervention Strategies to Bolster HIV Testing11
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?11
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups11
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure11
0.025820970535278